Serum protein marker for indicating healthy aging key pathway and application thereof
A protein and marker technology, applied in the field of biomedicine, can solve problems such as inability to industrialize, no technical means to evaluate healthy aging, and complex technical means.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0014] Example 1 Key pathways of healthy aging based on serum protein markers
[0015] Through mass spectrometry quantitative data analysis of serum proteome of 119 long-lived elderly (95-111 years old, median 100 years old) and 151 elderly control populations (32-80 years old, median 61 years old) in Hainan Province, The present invention provides a key pathway of healthy aging based on serum protein and a serum protein marker indicating the key pathway of healthy aging, wherein the key pathway of healthy aging based on serum protein includes 12 up-regulated pathways and 4 down-regulated pathways:
[0016] a), Up-regulated pathways are:
[0017]Wound healing; Hemostasis, blood coagulation, fibrin clot formation; Humoral immune response; Defense response to bacteria; Acute inflammatory response (acute inflammatory response); Binding and Uptake of Ligands by Scavenger Receptors; axon development; bone growth; ossification; vascular development (blood vessel development); axon...
Embodiment 2
[0024] Example 2 Serum Protein Markers Indicating Key Pathways of Healthy Aging in Example 1
[0025] The present invention also provides a new class of serum protein markers that indicate key pathways of healthy aging. These markers can be used alone or in combination of two or more to assess changes in key pathways of healthy aging, including 193, Among them, the 158 serum protein markers up-regulated include:
[0026]α-2 macroglobulin (A2, M Alpha-2-macroglobulin), plasma protease C1 inhibitor (SERPING1, Plasma protease C1 inhibitor), collagen α-1 (I) chain (COL1A1, Collagen alpha-1 (I) chain), collagen α-2 (I) chain (COL1A2, Collagen alpha-2 (I) chain), collagen α-1 (V) chain (COL5A1, Collagen alpha-1 (V) chain), cartilage oligomerization Matrix protein (COMP, Cartilage oligomericmatrix protein), dystrophin (DAG1, Dystroglycan), type A ephrin receptor 4 (EPHA4, Ephrintype-A receptor 4), coagulation factor VIII (F8, Coagulation factor VIII), granulin Precursor (GRN, Granu...
Embodiment 3
[0046] Example 3 Carry out assessment of healthy aging with bone growth (bone growth) this pathway:
[0047] The specific implementation method is as follows:
[0048] 1. Professional medical staff draw blood from at least 3 subjects (at least 3 samples are required to calculate the average protein abundance), obtain serum samples by centrifugation, and store them at -80°C;
[0049] 2. Measure the expression abundance of apolipoprotein L1 in serum samples: For example, through the relative quantitative method based on the mass spectrometry platform (Q-Exactive) - TMT, to obtain the 4 proteins contained in the functional enrichment of bone growth: COL6A1 , COL6A3, COL12A1, COMP expression abundance, the detailed steps are as follows:
[0050] a). Protein extraction: Serum samples were taken out from -80°C, centrifuged at 12,000g for 10 minutes at 4°C to remove cell debris, and the supernatant was transferred to a new centrifuge tube. The kit produced by Thermo was referred to ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com